Pivotal trial demonstrated avacopan’s statistical superiority in sustaining remission at 52 weeks over the glucocorticoid-containing standard-of-care therapy MOUNTAIN VIEW, Calif., June 03, 2020 ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
Investigators reported findings from one of the largest retrospective observational studies on ANCA-associated vasculitis. PHILADELPHIA—Patients with ANCA-associated vasculitis (AAV) present with ...
-- Rapid reduction in kidney inflammation following avacopan treatment in patients with ANCA-Associated Vasculitis revealed by analysis of markers of kidney damage -- -- Podocyte protection ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Despite advances in biologic therapies, “excess steroid use” remains a mainstay of treatment for ...
Credit: Getty Images Men have higher serum creatinine levels at presentation and are more likely to start dialysis within 4 weeks of diagnosis compared with women. PHILADELPHIA—Investigators who ...
Please provide your email address to receive an email when new articles are posted on . Targeting the complement pathway using a C5a agonist may be a “game changer” in anti-neutrophil cytoplasmic ...
Everyday Health on MSN
6 reasons to feel hopeful about an ANCA-associated vasculitis diagnosis
Read about reasons to feel hopeful about an ANCA-associated vasculitis diagnosis.
Our patient presented with a systemic illness in the setting of PTU use. The most severe manifestations of his illness were his pulmonary and kidney disorders. The finding of diffuse alveolar ...
San Antonio, TX - Rituximab (Rituxan, Genentech) also holds promise in the treatment of severe antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis in addition to rheumatoid arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results